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Abstract
Second Generation sub-population HIV Surveillance was undertaken in Kashgar City and Shache
County, Xinjiang, Peoples Republic of China between December 2003 and January 2004, targeting
injecting and mixed method drug users and pregnant and postnatal women. The study aimed to
determine the extent to which the epidemic is shifting from a concentrated stage to a more
generalised epidemic. One hundred and forty two (142) exclusively injecting drug users (66) and
mixed method drug users (injecting and non-injecting-76) participated in this survey. Eight hundred
and two (802) pregnant and postnatal women participated in the survey. In Kashgar City and Shache
County the serum prevalence of HIV amongst injecting drug users was 56.06%, for mixed method
drug users 48.68% and 0.38% in pregnant women. In Shache County HIV infection rates were
significantly lower in drug user groups and amongst pregnant and post-natal women, at 2.22% and
0% respectively. The behavioral survey indicated that 15% of injecting drug users have shared
needles (however sero prevalence and knowledge in relation to access to clean needles and
syringes suggests that this may not reflect the actual situation). Knowledge of prevention of
transmission strategies (not sharing needles and condom utilisation) is similar between both groups
at 60–70%. However it appears that this knowledge has not significantly impacted on behavior such
as needle sharing and condom utilisation. In Kashgar City and Shache County there have been very
few interventions to support HIV/AIDS prevention, care and control. The results from this survey
will inform future directions and the development and implementation of targeted interventions
including targeted information dissemination and harm reduction strategies.
This survey was funded by the Xinjiang HIV/AIDS Prevention and Care Project, a bilateral project jointly
implemented by the Government of the People's Republic of China and the Government of Australia.
Background
The secondary surveillance survey was carried out in Kash-
gar City and Shache County in December 2003 to January
2004. These two areas are within Kashgar Prefecture. The
distance between the two is 220 km. The aim of survey
was to determine the potential scope of the HIV/AIDS epi-
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demic in Kashgar and whether there was evidence to sug-
gest that this had changed from a concentrated epidemic
to a generalised one. There was a cumulative total of 160
HIV positive people in Kashgar Prefecture in June 2003
[1]. These low numbers were of concern when compared
with other parts of Xinjiang (in Yining and Urumqi City
where the numbers were over 3000 people in both sites)
where injecting drug use was high. The survey was man-
aged by the Xinjiang Regional AIDS Prevention Center at
the Center for Disease Control (CDC) in collaboration
with the Kashgar Prefecture CDC. The results of the survey
will be used to inform the development of targeted inter-
ventions to specific populations.
Methods
The 400 participants in the drug user group were regis-
tered and unregistered drug users. Among them 310 were
from Kashgar City and 90 from Shache County. Partici-
pants were mostly men (87.8%) however 49 women par-
ticipated (12.3%). In the drug user group 142 participants
identified themselves as being injecting or mixed method
drug users. Serum samples from 802 antenatal and post-
natal women were used for this survey. There were 540
participants from Shache County and 262 were from
Kashgar City.
The survey was undertaken using anonymous and
unlinked serum sampling and a behavioral survey. Inves-
tigators confirmed the number of samples by equal prob-
ability clustered random sampling. Stratified equal
opportunity random sampling was used based on distri-
bution of potential participants using specific settings (for
example closed and open settings for drug users). All par-
ticipants were aware that they were participating in the
survey and signed a consent form to have blood taken.
Behavioural questionnaires
All participants completed behavioral questionnaires dur-
ing face-to-face interviews. The questionnaires included
information on general health, knowledge about HIV/
AIDS, attitudes to people living with HIV/AIDS (PLWHA),
beliefs in relation to HIV/AIDS prevention and identified
at-risk behaviors for HIV/AIDS transmission. At the same
time a 5 ml blood sample was taken for serum analysis.
Serum analysis
Serum analysis for HIV/AIDS was carried out using two
ELISA tests on each blood sample. Where both tests were
positive this was considered an HIV positive result. Anti -
HIV-1/HIV-2 enzyme immunoassay and anti -HIV- 1/
HIV-2 enzyme immunoassay were used.
Results
HIV prevalence
In the drug user group the sero-prevalence of HIV/AIDS
(24.5%) was significantly higher than in the pregnant and
postnatal women group (0.13%) indicating that the epi-
demic remains predominantly within the drug using com-
munity. In the injecting and mixed method group (35%
of the drug user group) HIV prevalence was significantly
higher (56.06% and 48.68% respectively) than in the
non-injecting group (8.91%).
When results are disaggregated by area the seroprevalence
of HIV was higher in Kashgar City for drug users than
pregnant and postnatal women (30.65% and 0.38%
respectively) than in Shache County (2.22% and 0%
respectively). HIV seroprevalence in the injecting drug
user population for Kashgar City (51.42%) indicates a sig-
nificant HIV epidemic for this population while in Shache
County the number of injecting drug users was too small
(2) to draw a conclusion.
In recent years there are more reports of HIV in women. In
Xinjiang in 2003 (case reporting data) the prevalence of
HIV in women was 2.85% for sexual intercourse as the
route of transmission and 4.91% from other routes.
Women now represent 13.0% of reported cases in Xin-
jiang [1,2]. In the drug user group for this surveillance the
seroprevalence is 4.87% higher in women compared to
men.
Injecting drug users who are women are significantly less
affected by HIV than men (33% compared to 50.4%
respectively). However, when comparing the non-inject-
ing HIV positive group women have a higher prevalence
than men (12.9% and 8.29% respectively).
Behavioral factors impacting on HIV prevalence
Knowledge in relation to HIV/AIDS transmission routes
ranged between 60–70% for both groups however the
pregnant and postnatal women group had higher levels of
understanding (40–50%) in relation to how HIV/AIDS is
not transmitted than the drug user group (20–30%).
One variable affecting knowledge and skills is basic edu-
cation [3]. However there is little variation in basic educa-
tion between the groups. Location may have an impact on
access to higher level education. In a study in Urumqi City
17% of drug users had education to vocational or univer-
sity education level [4].
Access to information through health services may be a
determinant of the differences in knowledge between the
two groups. The majority of the pregnant and postnatal
women group had received regular antenatal checks
where information is provided (686 or 85.5%).Harm Reduction Journal 2006, 3:7 http://www.harmreductionjournal.com/content/3/1/7
Page 3 of 4
(page number not for citation purposes)
Knowledge does not appear to translate into skills such as
not sharing injecting equipment and using condoms.
Needle sharing is regarded as a common practice in the
drug using community in Xinjiang and contributes to the
transmission amongst injecting drug users [5,6]. In the
behavioral survey only 15% of drug users indicated that
they had shared needles in the last month and last six
months. However, 34.7% of all participants did not know
where to get clean syringes and needles and 37% of partic-
ipants thought that it was difficult to find clean syringes
and needles.
Condom use was low in both groups participating in the
surveillance. HIV seroprevalence was significantly linked
to condom use in drug users (84.2% in those who had
never used a condom as compared to 6.5% in those using
a condom each time they had sexual contact).
Discussion
The epidemic in Kashgar City remains concentrated in the
drug using population and specifically in the injecting
drug using community. HIV prevalence differs between
the two sites with higher rates in Kashgar City than in
Shache County for drug users. In this survey there are also
significantly more injecting drug users in Kashgar City
(40.3%) compared to Shache County (2.22%). This indi-
cates behavioral differences and geographic barriers.
There are gender differences. Men who are injecting drug
users have higher seroprevalence than women injecting
drug users. Women amongst the non-injecting drug using
population have a higher HIV seroprevalence than their
male counterparts however the actual numbers of women
are low.
This may be indicative of women not identifying as inject-
ing drug users or alternatively their contracting HIV
through sexual transmission. Women in studies in Amer-
ica who participated in needle and syringe exchange pro-
grams were found to be more likely to have IDU sexual
partners than men [7]. A larger group of women would
have to be surveyed to provide indicative results in rela-
tion to the impact of gender.
Reported needle and syringe sharing was 15% as com-
pared to 60% reported in another city in Xinjiang and in
other parts of China [5]. However there are many varia-
bles affecting perceptions of needle and syringe sharing.
These include needle sharing being understood as the pro-
vider of the needle or syringe being the "equipment
sharer" while the recipient is not [8]; knowledge that nee-
dle and syringe sharing is not an allowable practice and
therefore was not reported; needle sharing not occurring
at each event of drug use; and, a misunderstanding of the
behavioral questionnaire or a communication issue
between the interviewer and the participant.
For the pregnant and postnatal women group condom use
was also very low. Factors such as marital status and pre-
sumptive protection related to this, cultural norms related
to postnatal sexual relations between couples and the pre-
dominant view that condoms are considered to prevent
pregnancy influence results for this group.
Levels of knowledge in relation to transmission appear to
relate to access to the health system. However, lack of
knowledge in relation to how HIV/AIDS is not transmit-
ted raises issues in reducing stigma and discrimination in
the community towards people living with HIV/AIDS.
Conclusion
The findings of this survey indicate several key areas of
focus for future interventions. These would aim to
increase access to knowledge and skills in the general
community and in both groups participating in the study.
Targeting strategies and implementation programs are
critical. Strategies such as peer education have been suc-
cessfully used to expand a comprehensive harm reduction
program in Yining City [9] and this could be applied more
broadly in the context. Expansion of harm reduction pro-
grams including needle and syringe exchange and access
to condoms for injecting drug users is a priority particu-
larly in Kashgar City.
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